Julphar
Mohamed Nabil is an experienced pharmaceutical professional with a strong background in portfolio management and marketing. Currently serving as Global Portfolio Manager at Julphar since April 2018, Mohamed oversees pain management and cough, cold, and allergy product portfolios. Prior experience includes roles as Group Product Manager at e-pharma, managing CNS and nutrition portfolios, and Senior Product Manager at ARAC Healthcare, handling various consumer and CNS products. Early career positions involved medical representative roles at SPIMACO, sanofi-aventis, and EPCI. Mohamed holds an MBA in Marketing from the University of Leicester and a Bachelor of Pharmacy from Tanta University.
This person is not in any offices
Julphar
2 followers
The Julphar story is one of innovation and leadership. Since our journey began in 1980, our goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 2,500 people worldwide, and we market our products in more than 50 countries. We have 13 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines. Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.